FCGR2A and atherosclerosis: This indicates a deficient pro-atherogenic immune activation in the artery and also a key role of T regulatory cell function in FcγR deficient mice, consistent with previous studies of the protective effect of T regulatory cells in atherosclerosis progression [19], [44].